BlackRock Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $44K | Buy |
4,287
+588
| +16% | +$6.04K | ﹤0.01% | 2910 |
|
|
2016
Q3 | $37K | Buy |
3,699
+252
| +7% | +$2.52K | ﹤0.01% | 2930 |
|
|
2016
Q2 | $39K | Sell |
3,447
-84
| -2% | -$950 | ﹤0.01% | 2940 |
|
|
2016
Q1 | $48K | Sell |
3,531
-14,850
| -81% | -$202K | ﹤0.01% | 2913 |
|
|
2015
Q4 | $348K | Buy |
18,381
+5,225
| +40% | +$98.9K | ﹤0.01% | 2332 |
|
|
2015
Q3 | $247K | Buy |
+13,156
| New | +$247K | ﹤0.01% | 2446 |
|
|
2015
Q2 | – | Sell |
-23,299
| Closed | -$353K | – | 2947 |
|
|
2015
Q1 | $353K | Sell |
23,299
-20,269
| -47% | -$307K | ﹤0.01% | 2299 |
|
|
2014
Q4 | $580K | Sell |
43,568
-29,887
| -41% | -$398K | ﹤0.01% | 2171 |
|
|
2014
Q3 | $926K | Sell |
73,455
-108,516
| -60% | -$1.37M | ﹤0.01% | 1820 |
|
|
2014
Q2 | $1.84M | Buy |
181,971
+99,771
| +121% | +$1.01M | ﹤0.01% | 1482 |
|
|
2014
Q1 | $1.11M | Buy |
+82,200
| New | +$1.11M | ﹤0.01% | 1920 |
|